Profil
Jean Combalbert is the founder of Epics Therapeutics SA, serving as Director since 2018.
Current job includes Chairman at Syndesi Therapeutics SA. Former jobs include Chairman & Chief Executive Officer at Entomed SA from 2003 to 2009, Chief Executive Officer & Director at Ogeda SA, Non-Executive Chairman at Bioxodes SA, Director at Pharnext SA from 2020 to 2021, and Principal at Sanofi.
Education includes a doctorate from the University of Marseille.
Aktiva positioner av Jean Combalbert
| Företag | Position | Start |
|---|---|---|
Epics Therapeutics SA
Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Grundare | 2018-02-20 |
Syndesi Therapeutics SA
Syndesi Therapeutics SA BiotechnologyHealth Technology Develops treatments for CNS disorders | Ordförande | - |
Tidigare kända positioner av Jean Combalbert
| Företag | Position | Slut |
|---|---|---|
| PHARNEXT SCA | Direktör/Styrelseledamot | 2021-07-15 |
Entomed SA
Entomed SA Pharmaceuticals: MajorHealth Technology Discovers and develops anti-infective drugs derived from insects | Ordförande | 2009-02-03 |
Bioxodes SA
Bioxodes SA BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapeutics targeting thrombo-inflammation | Ordförande | - |
| SANOFI | Företagsledare/Principal | - |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Verkställande Direktör | - |
Jean Combalberts utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Entomed SA
Entomed SA Pharmaceuticals: MajorHealth Technology Discovers and develops anti-infective drugs derived from insects | Health Technology |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
University of Marseille
University of Marseille Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharnext SA
Pharnext SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for patients to treat neurodegenerative diseases | Health Technology |
Bioxodes SA
Bioxodes SA BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapeutics targeting thrombo-inflammation | Health Technology |
Syndesi Therapeutics SA
Syndesi Therapeutics SA BiotechnologyHealth Technology Develops treatments for CNS disorders | Health Technology |
Epics Therapeutics SA
Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
















